Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.
Novo Nordisk stock jumps 6% after drugmaker hikes forcast as Wegovy pill sales smash forecasts
Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.